nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—Folic Acid Metabolism Inhibitors—Methotrexate—germ cell cancer	0.39	1	CiPCiCtD
Pemetrexed—Methotrexate—germ cell cancer	0.255	1	CrCtD
Pemetrexed—ATIC—Methotrexate—germ cell cancer	0.0515	0.377	CbGbCtD
Pemetrexed—SLC46A1—Methotrexate—germ cell cancer	0.0409	0.299	CbGbCtD
Pemetrexed—Leucovorin—Methotrexate—germ cell cancer	0.0338	0.2	CrCrCtD
Pemetrexed—Pralatrexate—Methotrexate—germ cell cancer	0.0338	0.2	CrCrCtD
Pemetrexed—Raltitrexed—Methotrexate—germ cell cancer	0.0338	0.2	CrCrCtD
Pemetrexed—Tetrahydrofolic acid—Methotrexate—germ cell cancer	0.0338	0.2	CrCrCtD
Pemetrexed—Folic Acid—Methotrexate—germ cell cancer	0.0338	0.2	CrCrCtD
Pemetrexed—DHFR—Methotrexate—germ cell cancer	0.0261	0.191	CbGbCtD
Pemetrexed—TYMS—Methotrexate—germ cell cancer	0.0182	0.133	CbGbCtD
Pemetrexed—ATIC—pes—germ cell cancer	0.0021	0.0987	CbGeAlD
Pemetrexed—ATIC—appendage—germ cell cancer	0.000821	0.0385	CbGeAlD
Pemetrexed—ATIC—skin epidermis—germ cell cancer	0.000683	0.032	CbGeAlD
Pemetrexed—ATIC—ganglion—germ cell cancer	0.000575	0.027	CbGeAlD
Pemetrexed—GART—trigeminal ganglion—germ cell cancer	0.000416	0.0195	CbGeAlD
Pemetrexed—GART—eye—germ cell cancer	0.000358	0.0168	CbGeAlD
Pemetrexed—GART—telencephalon—germ cell cancer	0.000327	0.0153	CbGeAlD
Pemetrexed—GART—decidua—germ cell cancer	0.00031	0.0145	CbGeAlD
Pemetrexed—SLC46A1—eye—germ cell cancer	0.000291	0.0136	CbGeAlD
Pemetrexed—ATIC—embryo—germ cell cancer	0.000273	0.0128	CbGeAlD
Pemetrexed—GART—gonad—germ cell cancer	0.000273	0.0128	CbGeAlD
Pemetrexed—GART—pituitary gland—germ cell cancer	0.000266	0.0125	CbGeAlD
Pemetrexed—GART—medulla oblongata—germ cell cancer	0.000257	0.012	CbGeAlD
Pemetrexed—SLC46A1—decidua—germ cell cancer	0.000251	0.0118	CbGeAlD
Pemetrexed—ATIC—brainstem—germ cell cancer	0.00025	0.0117	CbGeAlD
Pemetrexed—ATIC—eye—germ cell cancer	0.000243	0.0114	CbGeAlD
Pemetrexed—ATIC—retina—germ cell cancer	0.000241	0.0113	CbGeAlD
Pemetrexed—GART—adrenal gland—germ cell cancer	0.000238	0.0111	CbGeAlD
Pemetrexed—GART—midbrain—germ cell cancer	0.000235	0.011	CbGeAlD
Pemetrexed—GART—bone marrow—germ cell cancer	0.00023	0.0108	CbGeAlD
Pemetrexed—GART—spinal cord—germ cell cancer	0.000229	0.0107	CbGeAlD
Pemetrexed—ATIC—telencephalon—germ cell cancer	0.000222	0.0104	CbGeAlD
Pemetrexed—GART—female gonad—germ cell cancer	0.000221	0.0104	CbGeAlD
Pemetrexed—TYMS—Vinorelbine—Vinblastine—germ cell cancer	0.000218	0.35	CbGdCrCtD
Pemetrexed—TYMS—Podofilox—Etoposide—germ cell cancer	0.000218	0.35	CbGdCrCtD
Pemetrexed—SLC46A1—pituitary gland—germ cell cancer	0.000216	0.0101	CbGeAlD
Pemetrexed—ATIC—skin of body—germ cell cancer	0.000212	0.00993	CbGeAlD
Pemetrexed—GART—endocrine gland—germ cell cancer	0.000206	0.00966	CbGeAlD
Pemetrexed—GART—head—germ cell cancer	0.000203	0.00954	CbGeAlD
Pemetrexed—GART—testis—germ cell cancer	0.000196	0.00921	CbGeAlD
Pemetrexed—SLC46A1—adrenal gland—germ cell cancer	0.000193	0.00904	CbGeAlD
Pemetrexed—DHFR—trigeminal ganglion—germ cell cancer	0.00019	0.00889	CbGeAlD
Pemetrexed—TYMS—Vincristine—Vinblastine—germ cell cancer	0.000186	0.299	CbGdCrCtD
Pemetrexed—SLC46A1—spinal cord—germ cell cancer	0.000186	0.00871	CbGeAlD
Pemetrexed—ATIC—gonad—germ cell cancer	0.000185	0.00868	CbGeAlD
Pemetrexed—ATIC—uterus—germ cell cancer	0.000184	0.00862	CbGeAlD
Pemetrexed—DHFR—embryo—germ cell cancer	0.000183	0.00859	CbGeAlD
Pemetrexed—GART—cerebellum—germ cell cancer	0.000181	0.00851	CbGeAlD
Pemetrexed—SLC46A1—female gonad—germ cell cancer	0.00018	0.00843	CbGeAlD
Pemetrexed—SLC29A1—trigeminal ganglion—germ cell cancer	0.000172	0.00806	CbGeAlD
Pemetrexed—SLC46A1—endocrine gland—germ cell cancer	0.000167	0.00784	CbGeAlD
Pemetrexed—SLC46A1—head—germ cell cancer	0.000165	0.00774	CbGeAlD
Pemetrexed—DCK—trigeminal ganglion—germ cell cancer	0.000164	0.0077	CbGeAlD
Pemetrexed—DHFR—eye—germ cell cancer	0.000163	0.00766	CbGeAlD
Pemetrexed—DHFR—retina—germ cell cancer	0.000162	0.00759	CbGeAlD
Pemetrexed—ATIC—adrenal gland—germ cell cancer	0.000161	0.00757	CbGeAlD
Pemetrexed—SLC46A1—testis—germ cell cancer	0.000159	0.00748	CbGeAlD
Pemetrexed—ATIC—midbrain—germ cell cancer	0.000159	0.00747	CbGeAlD
Pemetrexed—DCK—embryo—germ cell cancer	0.000158	0.00743	CbGeAlD
Pemetrexed—ATIC—spinal cord—germ cell cancer	0.000155	0.00729	CbGeAlD
Pemetrexed—ATIC—female gonad—germ cell cancer	0.00015	0.00705	CbGeAlD
Pemetrexed—TYMS—telencephalon—germ cell cancer	0.00015	0.00705	CbGeAlD
Pemetrexed—DHFR—telencephalon—germ cell cancer	0.000149	0.00698	CbGeAlD
Pemetrexed—GART—brain—germ cell cancer	0.000147	0.00691	CbGeAlD
Pemetrexed—SLC46A1—cerebellum—germ cell cancer	0.000147	0.00691	CbGeAlD
Pemetrexed—TYMS—skin of body—germ cell cancer	0.000144	0.00673	CbGeAlD
Pemetrexed—GART—lymph node—germ cell cancer	0.000142	0.00668	CbGeAlD
Pemetrexed—DHFR—decidua—germ cell cancer	0.000141	0.00662	CbGeAlD
Pemetrexed—DCK—retina—germ cell cancer	0.00014	0.00657	CbGeAlD
Pemetrexed—ATIC—endocrine gland—germ cell cancer	0.00014	0.00656	CbGeAlD
Pemetrexed—ATIC—head—germ cell cancer	0.000138	0.00648	CbGeAlD
Pemetrexed—SLC29A1—telencephalon—germ cell cancer	0.000135	0.00633	CbGeAlD
Pemetrexed—ATIC—testis—germ cell cancer	0.000133	0.00626	CbGeAlD
Pemetrexed—DCK—telencephalon—germ cell cancer	0.000129	0.00604	CbGeAlD
Pemetrexed—SLC29A1—decidua—germ cell cancer	0.000128	0.006	CbGeAlD
Pemetrexed—TYMS—gonad—germ cell cancer	0.000126	0.00589	CbGeAlD
Pemetrexed—DHFR—gonad—germ cell cancer	0.000124	0.00583	CbGeAlD
Pemetrexed—DHFR—uterus—germ cell cancer	0.000123	0.00579	CbGeAlD
Pemetrexed—ATIC—cerebellum—germ cell cancer	0.000123	0.00578	CbGeAlD
Pemetrexed—DCK—decidua—germ cell cancer	0.000122	0.00573	CbGeAlD
Pemetrexed—DHFR—pituitary gland—germ cell cancer	0.000121	0.00569	CbGeAlD
Pemetrexed—SLC46A1—brain—germ cell cancer	0.00012	0.00561	CbGeAlD
Pemetrexed—DHFR—medulla oblongata—germ cell cancer	0.000117	0.00549	CbGeAlD
Pemetrexed—SLC46A1—lymph node—germ cell cancer	0.000116	0.00542	CbGeAlD
Pemetrexed—SLC29A1—gonad—germ cell cancer	0.000113	0.00528	CbGeAlD
Pemetrexed—SLC29A1—uterus—germ cell cancer	0.000112	0.00525	CbGeAlD
Pemetrexed—SLC29A1—pituitary gland—germ cell cancer	0.00011	0.00515	CbGeAlD
Pemetrexed—TYMS—adrenal gland—germ cell cancer	0.000109	0.00513	CbGeAlD
Pemetrexed—DHFR—adrenal gland—germ cell cancer	0.000108	0.00508	CbGeAlD
Pemetrexed—TYMS—midbrain—germ cell cancer	0.000108	0.00507	CbGeAlD
Pemetrexed—DCK—gonad—germ cell cancer	0.000108	0.00504	CbGeAlD
Pemetrexed—DHFR—Trans-sulfuration and one carbon metabolism—DNMT3L—germ cell cancer	0.000107	0.127	CbGpPWpGaD
Pemetrexed—DHFR—midbrain—germ cell cancer	0.000107	0.00502	CbGeAlD
Pemetrexed—DCK—uterus—germ cell cancer	0.000107	0.00501	CbGeAlD
Pemetrexed—TYMS—bone marrow—germ cell cancer	0.000106	0.00496	CbGeAlD
Pemetrexed—DCK—pituitary gland—germ cell cancer	0.000105	0.00492	CbGeAlD
Pemetrexed—DHFR—bone marrow—germ cell cancer	0.000105	0.00491	CbGeAlD
Pemetrexed—DHFR—spinal cord—germ cell cancer	0.000104	0.00489	CbGeAlD
Pemetrexed—TYMS—female gonad—germ cell cancer	0.000102	0.00478	CbGeAlD
Pemetrexed—DCK—medulla oblongata—germ cell cancer	0.000101	0.00475	CbGeAlD
Pemetrexed—DHFR—female gonad—germ cell cancer	0.000101	0.00474	CbGeAlD
Pemetrexed—ATIC—brain—germ cell cancer	0.0001	0.00469	CbGeAlD
Pemetrexed—SLC29A1—adrenal gland—germ cell cancer	9.81e-05	0.0046	CbGeAlD
Pemetrexed—ATIC—lymph node—germ cell cancer	9.67e-05	0.00454	CbGeAlD
Pemetrexed—SLC29A1—bone marrow—germ cell cancer	9.49e-05	0.00445	CbGeAlD
Pemetrexed—TYMS—endocrine gland—germ cell cancer	9.49e-05	0.00445	CbGeAlD
Pemetrexed—DHFR—endocrine gland—germ cell cancer	9.39e-05	0.00441	CbGeAlD
Pemetrexed—DCK—adrenal gland—germ cell cancer	9.37e-05	0.0044	CbGeAlD
Pemetrexed—TYMS—head—germ cell cancer	9.37e-05	0.00439	CbGeAlD
Pemetrexed—TYMS—Trans-sulfuration and one carbon metabolism—DNMT3L—germ cell cancer	9.36e-05	0.111	CbGpPWpGaD
Pemetrexed—DHFR—head—germ cell cancer	9.27e-05	0.00435	CbGeAlD
Pemetrexed—DCK—midbrain—germ cell cancer	9.25e-05	0.00434	CbGeAlD
Pemetrexed—SLC29A1—female gonad—germ cell cancer	9.15e-05	0.00429	CbGeAlD
Pemetrexed—DCK—bone marrow—germ cell cancer	9.07e-05	0.00425	CbGeAlD
Pemetrexed—TYMS—testis—germ cell cancer	9.05e-05	0.00424	CbGeAlD
Pemetrexed—DCK—spinal cord—germ cell cancer	9.03e-05	0.00423	CbGeAlD
Pemetrexed—DHFR—testis—germ cell cancer	8.96e-05	0.0042	CbGeAlD
Pemetrexed—DCK—female gonad—germ cell cancer	8.74e-05	0.0041	CbGeAlD
Pemetrexed—SLC29A1—endocrine gland—germ cell cancer	8.51e-05	0.00399	CbGeAlD
Pemetrexed—SLC29A1—head—germ cell cancer	8.4e-05	0.00394	CbGeAlD
Pemetrexed—TYMS—cerebellum—germ cell cancer	8.36e-05	0.00392	CbGeAlD
Pemetrexed—DHFR—cerebellum—germ cell cancer	8.27e-05	0.00388	CbGeAlD
Pemetrexed—DCK—endocrine gland—germ cell cancer	8.13e-05	0.00381	CbGeAlD
Pemetrexed—SLC29A1—testis—germ cell cancer	8.11e-05	0.00381	CbGeAlD
Pemetrexed—DCK—head—germ cell cancer	8.02e-05	0.00376	CbGeAlD
Pemetrexed—DCK—testis—germ cell cancer	7.75e-05	0.00364	CbGeAlD
Pemetrexed—SLC29A1—cerebellum—germ cell cancer	7.49e-05	0.00351	CbGeAlD
Pemetrexed—DCK—cerebellum—germ cell cancer	7.16e-05	0.00336	CbGeAlD
Pemetrexed—Erythema—Bleomycin—germ cell cancer	7.07e-05	0.00268	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Etoposide—germ cell cancer	6.99e-05	0.00265	CcSEcCtD
Pemetrexed—Hepatitis—Ifosfamide—germ cell cancer	6.94e-05	0.00263	CcSEcCtD
Pemetrexed—Urinary tract disorder—Ifosfamide—germ cell cancer	6.86e-05	0.0026	CcSEcCtD
Pemetrexed—Dysphagia—Etoposide—germ cell cancer	6.85e-05	0.00259	CcSEcCtD
Pemetrexed—Urethral disorder—Ifosfamide—germ cell cancer	6.81e-05	0.00258	CcSEcCtD
Pemetrexed—TYMS—brain—germ cell cancer	6.79e-05	0.00318	CbGeAlD
Pemetrexed—DHFR—brain—germ cell cancer	6.72e-05	0.00315	CbGeAlD
Pemetrexed—Alopecia—Dactinomycin—germ cell cancer	6.7e-05	0.00254	CcSEcCtD
Pemetrexed—Thrombocytopenia—Vinblastine—germ cell cancer	6.69e-05	0.00253	CcSEcCtD
Pemetrexed—Respiratory failure—Methotrexate—germ cell cancer	6.66e-05	0.00252	CcSEcCtD
Pemetrexed—Erythema—Dactinomycin—germ cell cancer	6.6e-05	0.0025	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Cisplatin—germ cell cancer	6.57e-05	0.00249	CcSEcCtD
Pemetrexed—Erythema multiforme—Ifosfamide—germ cell cancer	6.57e-05	0.00249	CcSEcCtD
Pemetrexed—TYMS—lymph node—germ cell cancer	6.56e-05	0.00308	CbGeAlD
Pemetrexed—Renal failure—Cisplatin—germ cell cancer	6.56e-05	0.00248	CcSEcCtD
Pemetrexed—Pulmonary embolism—Methotrexate—germ cell cancer	6.54e-05	0.00248	CcSEcCtD
Pemetrexed—Anaemia—Bleomycin—germ cell cancer	6.54e-05	0.00248	CcSEcCtD
Pemetrexed—Myocardial infarction—Cisplatin—germ cell cancer	6.54e-05	0.00248	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Cisplatin—germ cell cancer	6.54e-05	0.00248	CcSEcCtD
Pemetrexed—Anorexia—Vinblastine—germ cell cancer	6.51e-05	0.00247	CcSEcCtD
Pemetrexed—Pancytopenia—Etoposide—germ cell cancer	6.51e-05	0.00246	CcSEcCtD
Pemetrexed—Stomatitis—Cisplatin—germ cell cancer	6.5e-05	0.00246	CcSEcCtD
Pemetrexed—DHFR—lymph node—germ cell cancer	6.49e-05	0.00305	CbGeAlD
Pemetrexed—Eye disorder—Ifosfamide—germ cell cancer	6.49e-05	0.00246	CcSEcCtD
Pemetrexed—Conjunctivitis—Cisplatin—germ cell cancer	6.48e-05	0.00245	CcSEcCtD
Pemetrexed—Neutropenia—Etoposide—germ cell cancer	6.41e-05	0.00243	CcSEcCtD
Pemetrexed—Leukopenia—Bleomycin—germ cell cancer	6.33e-05	0.0024	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Cisplatin—germ cell cancer	6.31e-05	0.00239	CcSEcCtD
Pemetrexed—Skin exfoliation—Methotrexate—germ cell cancer	6.25e-05	0.00237	CcSEcCtD
Pemetrexed—Arrhythmia—Ifosfamide—germ cell cancer	6.2e-05	0.00235	CcSEcCtD
Pemetrexed—Alopecia—Ifosfamide—germ cell cancer	6.14e-05	0.00232	CcSEcCtD
Pemetrexed—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A3—germ cell cancer	6.13e-05	0.0728	CbGpPWpGaD
Pemetrexed—Infestation NOS—Etoposide—germ cell cancer	6.11e-05	0.00231	CcSEcCtD
Pemetrexed—Infestation—Etoposide—germ cell cancer	6.11e-05	0.00231	CcSEcCtD
Pemetrexed—Anaemia—Dactinomycin—germ cell cancer	6.1e-05	0.00231	CcSEcCtD
Pemetrexed—SLC29A1—brain—germ cell cancer	6.09e-05	0.00285	CbGeAlD
Pemetrexed—Stevens-Johnson syndrome—Etoposide—germ cell cancer	6.06e-05	0.00229	CcSEcCtD
Pemetrexed—Erythema—Ifosfamide—germ cell cancer	6.04e-05	0.00229	CcSEcCtD
Pemetrexed—Malnutrition—Ifosfamide—germ cell cancer	6.04e-05	0.00229	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Etoposide—germ cell cancer	6.02e-05	0.00228	CcSEcCtD
Pemetrexed—Chest pain—Bleomycin—germ cell cancer	6.02e-05	0.00228	CcSEcCtD
Pemetrexed—Myalgia—Bleomycin—germ cell cancer	6.02e-05	0.00228	CcSEcCtD
Pemetrexed—Renal failure—Etoposide—germ cell cancer	6.01e-05	0.00227	CcSEcCtD
Pemetrexed—Myocardial infarction—Etoposide—germ cell cancer	5.99e-05	0.00227	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Etoposide—germ cell cancer	5.99e-05	0.00227	CcSEcCtD
Pemetrexed—Stomatitis—Etoposide—germ cell cancer	5.95e-05	0.00226	CcSEcCtD
Pemetrexed—Decreased appetite—Vinblastine—germ cell cancer	5.94e-05	0.00225	CcSEcCtD
Pemetrexed—Urinary tract disorder—Cisplatin—germ cell cancer	5.91e-05	0.00224	CcSEcCtD
Pemetrexed—Leukopenia—Dactinomycin—germ cell cancer	5.9e-05	0.00224	CcSEcCtD
Pemetrexed—SLC29A1—lymph node—germ cell cancer	5.88e-05	0.00276	CbGeAlD
Pemetrexed—Urethral disorder—Cisplatin—germ cell cancer	5.87e-05	0.00222	CcSEcCtD
Pemetrexed—Pain—Vinblastine—germ cell cancer	5.84e-05	0.00221	CcSEcCtD
Pemetrexed—Constipation—Vinblastine—germ cell cancer	5.84e-05	0.00221	CcSEcCtD
Pemetrexed—DCK—brain—germ cell cancer	5.81e-05	0.00273	CbGeAlD
Pemetrexed—Hepatobiliary disease—Etoposide—germ cell cancer	5.78e-05	0.00219	CcSEcCtD
Pemetrexed—Anaphylactic shock—Bleomycin—germ cell cancer	5.77e-05	0.00219	CcSEcCtD
Pemetrexed—Oedema—Bleomycin—germ cell cancer	5.77e-05	0.00219	CcSEcCtD
Pemetrexed—Infection—Bleomycin—germ cell cancer	5.73e-05	0.00217	CcSEcCtD
Pemetrexed—Agranulocytosis—Etoposide—germ cell cancer	5.7e-05	0.00216	CcSEcCtD
Pemetrexed—Sepsis—Methotrexate—germ cell cancer	5.68e-05	0.00215	CcSEcCtD
Pemetrexed—Thrombocytopenia—Bleomycin—germ cell cancer	5.65e-05	0.00214	CcSEcCtD
Pemetrexed—DCK—lymph node—germ cell cancer	5.62e-05	0.00264	CbGeAlD
Pemetrexed—Myalgia—Dactinomycin—germ cell cancer	5.62e-05	0.00213	CcSEcCtD
Pemetrexed—Eye disorder—Cisplatin—germ cell cancer	5.59e-05	0.00212	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Vinblastine—germ cell cancer	5.59e-05	0.00212	CcSEcCtD
Pemetrexed—Anaemia—Ifosfamide—germ cell cancer	5.59e-05	0.00212	CcSEcCtD
Pemetrexed—Anorexia—Bleomycin—germ cell cancer	5.5e-05	0.00208	CcSEcCtD
Pemetrexed—Urinary tract disorder—Etoposide—germ cell cancer	5.42e-05	0.00205	CcSEcCtD
Pemetrexed—Leukopenia—Ifosfamide—germ cell cancer	5.41e-05	0.00205	CcSEcCtD
Pemetrexed—Abdominal pain—Vinblastine—germ cell cancer	5.4e-05	0.00205	CcSEcCtD
Pemetrexed—Oedema—Dactinomycin—germ cell cancer	5.38e-05	0.00204	CcSEcCtD
Pemetrexed—Urethral disorder—Etoposide—germ cell cancer	5.38e-05	0.00204	CcSEcCtD
Pemetrexed—Infection—Dactinomycin—germ cell cancer	5.35e-05	0.00203	CcSEcCtD
Pemetrexed—Arrhythmia—Cisplatin—germ cell cancer	5.35e-05	0.00203	CcSEcCtD
Pemetrexed—Alopecia—Cisplatin—germ cell cancer	5.29e-05	0.002	CcSEcCtD
Pemetrexed—Thrombocytopenia—Dactinomycin—germ cell cancer	5.27e-05	0.002	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Bleomycin—germ cell cancer	5.26e-05	0.00199	CcSEcCtD
Pemetrexed—Hypertension—Ifosfamide—germ cell cancer	5.22e-05	0.00198	CcSEcCtD
Pemetrexed—Malnutrition—Cisplatin—germ cell cancer	5.21e-05	0.00197	CcSEcCtD
Pemetrexed—Erythema—Cisplatin—germ cell cancer	5.21e-05	0.00197	CcSEcCtD
Pemetrexed—Erythema multiforme—Etoposide—germ cell cancer	5.19e-05	0.00196	CcSEcCtD
Pemetrexed—Dyspnoea—Bleomycin—germ cell cancer	5.15e-05	0.00195	CcSEcCtD
Pemetrexed—Arthralgia—Ifosfamide—germ cell cancer	5.15e-05	0.00195	CcSEcCtD
Pemetrexed—Myalgia—Ifosfamide—germ cell cancer	5.15e-05	0.00195	CcSEcCtD
Pemetrexed—Chest pain—Ifosfamide—germ cell cancer	5.15e-05	0.00195	CcSEcCtD
Pemetrexed—Renal failure acute—Methotrexate—germ cell cancer	5.14e-05	0.00195	CcSEcCtD
Pemetrexed—Anorexia—Dactinomycin—germ cell cancer	5.13e-05	0.00194	CcSEcCtD
Pemetrexed—Eye disorder—Etoposide—germ cell cancer	5.13e-05	0.00194	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	5.11e-05	0.00194	CcSEcCtD
Pemetrexed—Hypersensitivity—Vinblastine—germ cell cancer	5.04e-05	0.00191	CcSEcCtD
Pemetrexed—Decreased appetite—Bleomycin—germ cell cancer	5.02e-05	0.0019	CcSEcCtD
Pemetrexed—Pain—Bleomycin—germ cell cancer	4.94e-05	0.00187	CcSEcCtD
Pemetrexed—Anaphylactic shock—Ifosfamide—germ cell cancer	4.93e-05	0.00187	CcSEcCtD
Pemetrexed—Oedema—Ifosfamide—germ cell cancer	4.93e-05	0.00187	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	4.9e-05	0.00186	CcSEcCtD
Pemetrexed—Asthenia—Vinblastine—germ cell cancer	4.9e-05	0.00186	CcSEcCtD
Pemetrexed—Infection—Ifosfamide—germ cell cancer	4.9e-05	0.00186	CcSEcCtD
Pemetrexed—Alopecia—Etoposide—germ cell cancer	4.85e-05	0.00184	CcSEcCtD
Pemetrexed—Cerebrovascular accident—Methotrexate—germ cell cancer	4.85e-05	0.00184	CcSEcCtD
Pemetrexed—Nervous system disorder—Ifosfamide—germ cell cancer	4.84e-05	0.00183	CcSEcCtD
Pemetrexed—Thrombocytopenia—Ifosfamide—germ cell cancer	4.83e-05	0.00183	CcSEcCtD
Pemetrexed—Anaemia—Cisplatin—germ cell cancer	4.82e-05	0.00182	CcSEcCtD
Pemetrexed—Skin disorder—Ifosfamide—germ cell cancer	4.79e-05	0.00181	CcSEcCtD
Pemetrexed—Anorexia—Ifosfamide—germ cell cancer	4.7e-05	0.00178	CcSEcCtD
Pemetrexed—Decreased appetite—Dactinomycin—germ cell cancer	4.68e-05	0.00177	CcSEcCtD
Pemetrexed—Diarrhoea—Vinblastine—germ cell cancer	4.68e-05	0.00177	CcSEcCtD
Pemetrexed—Dysgeusia—Etoposide—germ cell cancer	4.68e-05	0.00177	CcSEcCtD
Pemetrexed—Leukopenia—Cisplatin—germ cell cancer	4.66e-05	0.00177	CcSEcCtD
Pemetrexed—Fatigue—Dactinomycin—germ cell cancer	4.64e-05	0.00176	CcSEcCtD
Pemetrexed—Pain—Dactinomycin—germ cell cancer	4.6e-05	0.00174	CcSEcCtD
Pemetrexed—Urticaria—Bleomycin—germ cell cancer	4.59e-05	0.00174	CcSEcCtD
Pemetrexed—Body temperature increased—Bleomycin—germ cell cancer	4.56e-05	0.00173	CcSEcCtD
Pemetrexed—Dizziness—Vinblastine—germ cell cancer	4.52e-05	0.00171	CcSEcCtD
Pemetrexed—Mood swings—Methotrexate—germ cell cancer	4.5e-05	0.0017	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	4.49e-05	0.0017	CcSEcCtD
Pemetrexed—Myalgia—Cisplatin—germ cell cancer	4.44e-05	0.00168	CcSEcCtD
Pemetrexed—Anaemia—Etoposide—germ cell cancer	4.41e-05	0.00167	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	4.41e-05	0.00167	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Dactinomycin—germ cell cancer	4.4e-05	0.00167	CcSEcCtD
Pemetrexed—Dyspnoea—Ifosfamide—germ cell cancer	4.4e-05	0.00167	CcSEcCtD
Pemetrexed—SLC29A1—Transport of vitamins, nucleosides, and related molecules—AVP—germ cell cancer	4.35e-05	0.0516	CbGpPWpGaD
Pemetrexed—Vomiting—Vinblastine—germ cell cancer	4.35e-05	0.00165	CcSEcCtD
Pemetrexed—Decreased appetite—Ifosfamide—germ cell cancer	4.29e-05	0.00162	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	4.28e-05	0.00162	CcSEcCtD
Pemetrexed—Leukopenia—Etoposide—germ cell cancer	4.27e-05	0.00162	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Ifosfamide—germ cell cancer	4.26e-05	0.00161	CcSEcCtD
Pemetrexed—Abdominal pain—Dactinomycin—germ cell cancer	4.26e-05	0.00161	CcSEcCtD
Pemetrexed—Body temperature increased—Dactinomycin—germ cell cancer	4.26e-05	0.00161	CcSEcCtD
Pemetrexed—Fatigue—Ifosfamide—germ cell cancer	4.25e-05	0.00161	CcSEcCtD
Pemetrexed—Anaphylactic shock—Cisplatin—germ cell cancer	4.25e-05	0.00161	CcSEcCtD
Pemetrexed—Oedema—Cisplatin—germ cell cancer	4.25e-05	0.00161	CcSEcCtD
Pemetrexed—Hypersensitivity—Bleomycin—germ cell cancer	4.25e-05	0.00161	CcSEcCtD
Pemetrexed—Infection—Cisplatin—germ cell cancer	4.23e-05	0.0016	CcSEcCtD
Pemetrexed—Pain—Ifosfamide—germ cell cancer	4.22e-05	0.0016	CcSEcCtD
Pemetrexed—Constipation—Ifosfamide—germ cell cancer	4.22e-05	0.0016	CcSEcCtD
Pemetrexed—Loss of consciousness—Etoposide—germ cell cancer	4.2e-05	0.00159	CcSEcCtD
Pemetrexed—Nervous system disorder—Cisplatin—germ cell cancer	4.17e-05	0.00158	CcSEcCtD
Pemetrexed—Thrombocytopenia—Cisplatin—germ cell cancer	4.16e-05	0.00158	CcSEcCtD
Pemetrexed—Asthenia—Bleomycin—germ cell cancer	4.14e-05	0.00157	CcSEcCtD
Pemetrexed—Skin disorder—Cisplatin—germ cell cancer	4.13e-05	0.00156	CcSEcCtD
Pemetrexed—Hypertension—Etoposide—germ cell cancer	4.12e-05	0.00156	CcSEcCtD
Pemetrexed—Pruritus—Bleomycin—germ cell cancer	4.08e-05	0.00155	CcSEcCtD
Pemetrexed—Chest pain—Etoposide—germ cell cancer	4.06e-05	0.00154	CcSEcCtD
Pemetrexed—Nausea—Vinblastine—germ cell cancer	4.06e-05	0.00154	CcSEcCtD
Pemetrexed—Anorexia—Cisplatin—germ cell cancer	4.05e-05	0.00154	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	4.04e-05	0.00153	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Ifosfamide—germ cell cancer	4.03e-05	0.00153	CcSEcCtD
Pemetrexed—Pancreatitis—Methotrexate—germ cell cancer	4.02e-05	0.00152	CcSEcCtD
Pemetrexed—Hypersensitivity—Dactinomycin—germ cell cancer	3.97e-05	0.0015	CcSEcCtD
Pemetrexed—Urticaria—Ifosfamide—germ cell cancer	3.92e-05	0.00148	CcSEcCtD
Pemetrexed—Body temperature increased—Ifosfamide—germ cell cancer	3.9e-05	0.00148	CcSEcCtD
Pemetrexed—Abdominal pain—Ifosfamide—germ cell cancer	3.9e-05	0.00148	CcSEcCtD
Pemetrexed—Pancytopenia—Methotrexate—germ cell cancer	3.9e-05	0.00148	CcSEcCtD
Pemetrexed—Anaphylactic shock—Etoposide—germ cell cancer	3.9e-05	0.00148	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Cisplatin—germ cell cancer	3.87e-05	0.00147	CcSEcCtD
Pemetrexed—Infection—Etoposide—germ cell cancer	3.87e-05	0.00147	CcSEcCtD
Pemetrexed—Asthenia—Dactinomycin—germ cell cancer	3.86e-05	0.00146	CcSEcCtD
Pemetrexed—Neutropenia—Methotrexate—germ cell cancer	3.84e-05	0.00145	CcSEcCtD
Pemetrexed—Thrombocytopenia—Etoposide—germ cell cancer	3.81e-05	0.00144	CcSEcCtD
Pemetrexed—Dyspnoea—Cisplatin—germ cell cancer	3.79e-05	0.00144	CcSEcCtD
Pemetrexed—Skin disorder—Etoposide—germ cell cancer	3.78e-05	0.00143	CcSEcCtD
Pemetrexed—Anorexia—Etoposide—germ cell cancer	3.71e-05	0.00141	CcSEcCtD
Pemetrexed—Decreased appetite—Cisplatin—germ cell cancer	3.7e-05	0.0014	CcSEcCtD
Pemetrexed—Diarrhoea—Dactinomycin—germ cell cancer	3.68e-05	0.00139	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Cisplatin—germ cell cancer	3.67e-05	0.00139	CcSEcCtD
Pemetrexed—Vomiting—Bleomycin—germ cell cancer	3.67e-05	0.00139	CcSEcCtD
Pemetrexed—Infestation NOS—Methotrexate—germ cell cancer	3.66e-05	0.00139	CcSEcCtD
Pemetrexed—Infestation—Methotrexate—germ cell cancer	3.66e-05	0.00139	CcSEcCtD
Pemetrexed—Rash—Bleomycin—germ cell cancer	3.64e-05	0.00138	CcSEcCtD
Pemetrexed—Pain—Cisplatin—germ cell cancer	3.64e-05	0.00138	CcSEcCtD
Pemetrexed—Dermatitis—Bleomycin—germ cell cancer	3.64e-05	0.00138	CcSEcCtD
Pemetrexed—Hypersensitivity—Ifosfamide—germ cell cancer	3.63e-05	0.00138	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	3.63e-05	0.00137	CcSEcCtD
Pemetrexed—Renal failure—Methotrexate—germ cell cancer	3.6e-05	0.00136	CcSEcCtD
Pemetrexed—Stomatitis—Methotrexate—germ cell cancer	3.57e-05	0.00135	CcSEcCtD
Pemetrexed—Conjunctivitis—Methotrexate—germ cell cancer	3.56e-05	0.00135	CcSEcCtD
Pemetrexed—Asthenia—Ifosfamide—germ cell cancer	3.54e-05	0.00134	CcSEcCtD
Pemetrexed—Pruritus—Ifosfamide—germ cell cancer	3.49e-05	0.00132	CcSEcCtD
Pemetrexed—Dyspnoea—Etoposide—germ cell cancer	3.47e-05	0.00132	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Methotrexate—germ cell cancer	3.46e-05	0.00131	CcSEcCtD
Pemetrexed—Nausea—Bleomycin—germ cell cancer	3.43e-05	0.0013	CcSEcCtD
Pemetrexed—Vomiting—Dactinomycin—germ cell cancer	3.42e-05	0.0013	CcSEcCtD
Pemetrexed—Agranulocytosis—Methotrexate—germ cell cancer	3.41e-05	0.00129	CcSEcCtD
Pemetrexed—Rash—Dactinomycin—germ cell cancer	3.39e-05	0.00129	CcSEcCtD
Pemetrexed—Decreased appetite—Etoposide—germ cell cancer	3.39e-05	0.00128	CcSEcCtD
Pemetrexed—Diarrhoea—Ifosfamide—germ cell cancer	3.38e-05	0.00128	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Etoposide—germ cell cancer	3.36e-05	0.00127	CcSEcCtD
Pemetrexed—Body temperature increased—Cisplatin—germ cell cancer	3.36e-05	0.00127	CcSEcCtD
Pemetrexed—Fatigue—Etoposide—germ cell cancer	3.36e-05	0.00127	CcSEcCtD
Pemetrexed—Pain—Etoposide—germ cell cancer	3.33e-05	0.00126	CcSEcCtD
Pemetrexed—Constipation—Etoposide—germ cell cancer	3.33e-05	0.00126	CcSEcCtD
Pemetrexed—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A3—germ cell cancer	3.29e-05	0.039	CbGpPWpGaD
Pemetrexed—Hepatitis—Methotrexate—germ cell cancer	3.29e-05	0.00124	CcSEcCtD
Pemetrexed—Dizziness—Ifosfamide—germ cell cancer	3.26e-05	0.00124	CcSEcCtD
Pemetrexed—Pharyngitis—Methotrexate—germ cell cancer	3.26e-05	0.00123	CcSEcCtD
Pemetrexed—Urinary tract disorder—Methotrexate—germ cell cancer	3.24e-05	0.00123	CcSEcCtD
Pemetrexed—Urethral disorder—Methotrexate—germ cell cancer	3.22e-05	0.00122	CcSEcCtD
Pemetrexed—Nausea—Dactinomycin—germ cell cancer	3.2e-05	0.00121	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Etoposide—germ cell cancer	3.19e-05	0.00121	CcSEcCtD
Pemetrexed—Vomiting—Ifosfamide—germ cell cancer	3.14e-05	0.00119	CcSEcCtD
Pemetrexed—Hypersensitivity—Cisplatin—germ cell cancer	3.13e-05	0.00119	CcSEcCtD
Pemetrexed—Rash—Ifosfamide—germ cell cancer	3.11e-05	0.00118	CcSEcCtD
Pemetrexed—Dermatitis—Ifosfamide—germ cell cancer	3.11e-05	0.00118	CcSEcCtD
Pemetrexed—Erythema multiforme—Methotrexate—germ cell cancer	3.11e-05	0.00118	CcSEcCtD
Pemetrexed—Urticaria—Etoposide—germ cell cancer	3.1e-05	0.00117	CcSEcCtD
Pemetrexed—Abdominal pain—Etoposide—germ cell cancer	3.08e-05	0.00117	CcSEcCtD
Pemetrexed—Body temperature increased—Etoposide—germ cell cancer	3.08e-05	0.00117	CcSEcCtD
Pemetrexed—Eye disorder—Methotrexate—germ cell cancer	3.07e-05	0.00116	CcSEcCtD
Pemetrexed—Asthenia—Cisplatin—germ cell cancer	3.05e-05	0.00116	CcSEcCtD
Pemetrexed—Nausea—Ifosfamide—germ cell cancer	2.93e-05	0.00111	CcSEcCtD
Pemetrexed—Diarrhoea—Cisplatin—germ cell cancer	2.91e-05	0.0011	CcSEcCtD
Pemetrexed—Alopecia—Methotrexate—germ cell cancer	2.9e-05	0.0011	CcSEcCtD
Pemetrexed—Hypersensitivity—Etoposide—germ cell cancer	2.87e-05	0.00109	CcSEcCtD
Pemetrexed—Erythema—Methotrexate—germ cell cancer	2.86e-05	0.00108	CcSEcCtD
Pemetrexed—Malnutrition—Methotrexate—germ cell cancer	2.86e-05	0.00108	CcSEcCtD
Pemetrexed—Dysgeusia—Methotrexate—germ cell cancer	2.8e-05	0.00106	CcSEcCtD
Pemetrexed—Asthenia—Etoposide—germ cell cancer	2.8e-05	0.00106	CcSEcCtD
Pemetrexed—Pruritus—Etoposide—germ cell cancer	2.76e-05	0.00104	CcSEcCtD
Pemetrexed—Vomiting—Cisplatin—germ cell cancer	2.7e-05	0.00102	CcSEcCtD
Pemetrexed—Rash—Cisplatin—germ cell cancer	2.68e-05	0.00102	CcSEcCtD
Pemetrexed—Dermatitis—Cisplatin—germ cell cancer	2.68e-05	0.00101	CcSEcCtD
Pemetrexed—Diarrhoea—Etoposide—germ cell cancer	2.67e-05	0.00101	CcSEcCtD
Pemetrexed—Anaemia—Methotrexate—germ cell cancer	2.64e-05	0.001	CcSEcCtD
Pemetrexed—Dizziness—Etoposide—germ cell cancer	2.58e-05	0.000976	CcSEcCtD
Pemetrexed—Leukopenia—Methotrexate—germ cell cancer	2.56e-05	0.000969	CcSEcCtD
Pemetrexed—Nausea—Cisplatin—germ cell cancer	2.53e-05	0.000957	CcSEcCtD
Pemetrexed—Vomiting—Etoposide—germ cell cancer	2.48e-05	0.000938	CcSEcCtD
Pemetrexed—Rash—Etoposide—germ cell cancer	2.46e-05	0.00093	CcSEcCtD
Pemetrexed—Dermatitis—Etoposide—germ cell cancer	2.45e-05	0.000929	CcSEcCtD
Pemetrexed—Myalgia—Methotrexate—germ cell cancer	2.43e-05	0.000922	CcSEcCtD
Pemetrexed—Arthralgia—Methotrexate—germ cell cancer	2.43e-05	0.000922	CcSEcCtD
Pemetrexed—Chest pain—Methotrexate—germ cell cancer	2.43e-05	0.000922	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	2.42e-05	0.000916	CcSEcCtD
Pemetrexed—Anaphylactic shock—Methotrexate—germ cell cancer	2.33e-05	0.000884	CcSEcCtD
Pemetrexed—Infection—Methotrexate—germ cell cancer	2.32e-05	0.000878	CcSEcCtD
Pemetrexed—Nausea—Etoposide—germ cell cancer	2.31e-05	0.000876	CcSEcCtD
Pemetrexed—Nervous system disorder—Methotrexate—germ cell cancer	2.29e-05	0.000867	CcSEcCtD
Pemetrexed—Thrombocytopenia—Methotrexate—germ cell cancer	2.29e-05	0.000865	CcSEcCtD
Pemetrexed—Skin disorder—Methotrexate—germ cell cancer	2.27e-05	0.000858	CcSEcCtD
Pemetrexed—Anorexia—Methotrexate—germ cell cancer	2.22e-05	0.000842	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Methotrexate—germ cell cancer	2.13e-05	0.000805	CcSEcCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	2.1e-05	0.0249	CbGpPWpGaD
Pemetrexed—Dyspnoea—Methotrexate—germ cell cancer	2.08e-05	0.000788	CcSEcCtD
Pemetrexed—GART—Folate Metabolism—TP53—germ cell cancer	2.06e-05	0.0244	CbGpPWpGaD
Pemetrexed—Dyspepsia—Methotrexate—germ cell cancer	2.05e-05	0.000778	CcSEcCtD
Pemetrexed—Decreased appetite—Methotrexate—germ cell cancer	2.03e-05	0.000768	CcSEcCtD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	2.03e-05	0.024	CbGpPWpGaD
Pemetrexed—Gastrointestinal disorder—Methotrexate—germ cell cancer	2.01e-05	0.000763	CcSEcCtD
Pemetrexed—Fatigue—Methotrexate—germ cell cancer	2.01e-05	0.000762	CcSEcCtD
Pemetrexed—Pain—Methotrexate—germ cell cancer	2e-05	0.000756	CcSEcCtD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	2e-05	0.0237	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	1.98e-05	0.0235	CbGpPWpGaD
Pemetrexed—Gastrointestinal pain—Methotrexate—germ cell cancer	1.91e-05	0.000723	CcSEcCtD
Pemetrexed—Urticaria—Methotrexate—germ cell cancer	1.85e-05	0.000702	CcSEcCtD
Pemetrexed—Body temperature increased—Methotrexate—germ cell cancer	1.84e-05	0.000699	CcSEcCtD
Pemetrexed—Abdominal pain—Methotrexate—germ cell cancer	1.84e-05	0.000699	CcSEcCtD
Pemetrexed—Hypersensitivity—Methotrexate—germ cell cancer	1.72e-05	0.000651	CcSEcCtD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	1.69e-05	0.02	CbGpPWpGaD
Pemetrexed—Asthenia—Methotrexate—germ cell cancer	1.67e-05	0.000634	CcSEcCtD
Pemetrexed—Pruritus—Methotrexate—germ cell cancer	1.65e-05	0.000625	CcSEcCtD
Pemetrexed—Diarrhoea—Methotrexate—germ cell cancer	1.6e-05	0.000605	CcSEcCtD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	1.57e-05	0.0187	CbGpPWpGaD
Pemetrexed—Dizziness—Methotrexate—germ cell cancer	1.54e-05	0.000584	CcSEcCtD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—TP53—germ cell cancer	1.54e-05	0.0182	CbGpPWpGaD
Pemetrexed—Vomiting—Methotrexate—germ cell cancer	1.48e-05	0.000562	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—H2AFZ—germ cell cancer	1.47e-05	0.0175	CbGpPWpGaD
Pemetrexed—Rash—Methotrexate—germ cell cancer	1.47e-05	0.000557	CcSEcCtD
Pemetrexed—Dermatitis—Methotrexate—germ cell cancer	1.47e-05	0.000557	CcSEcCtD
Pemetrexed—Nausea—Methotrexate—germ cell cancer	1.39e-05	0.000525	CcSEcCtD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.3e-05	0.0154	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.28e-05	0.0152	CbGpPWpGaD
Pemetrexed—GART—Metabolism—SLC2A3—germ cell cancer	1.13e-05	0.0134	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—TP53—germ cell cancer	1.11e-05	0.0132	CbGpPWpGaD
Pemetrexed—GART—Metabolism—SLC22A3—germ cell cancer	1.11e-05	0.0132	CbGpPWpGaD
Pemetrexed—DHFR—Fluoropyrimidine Activity—TP53—germ cell cancer	1.04e-05	0.0123	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	1.03e-05	0.0122	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	1.01e-05	0.012	CbGpPWpGaD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—AVP—germ cell cancer	9.34e-06	0.0111	CbGpPWpGaD
Pemetrexed—TYMS—Fluoropyrimidine Activity—TP53—germ cell cancer	9.07e-06	0.0108	CbGpPWpGaD
Pemetrexed—GART—Metabolism—CRABP1—germ cell cancer	9.04e-06	0.0107	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—SLC2A3—germ cell cancer	7.81e-06	0.00926	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—SLC22A3—germ cell cancer	7.69e-06	0.00912	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SLC2A3—germ cell cancer	7.26e-06	0.00861	CbGpPWpGaD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	7.25e-06	0.0086	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—AVP—germ cell cancer	6.77e-06	0.00803	CbGpPWpGaD
Pemetrexed—DHFR—E2F transcription factor network—MYC—germ cell cancer	6.71e-06	0.00795	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CRABP1—germ cell cancer	6.27e-06	0.00743	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—SLC2A3—germ cell cancer	6.08e-06	0.00721	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—SLC22A3—germ cell cancer	5.99e-06	0.0071	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—AVP—germ cell cancer	5.99e-06	0.0071	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—TP53—germ cell cancer	5.97e-06	0.00708	CbGpPWpGaD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	5.95e-06	0.00706	CbGpPWpGaD
Pemetrexed—TYMS—E2F transcription factor network—MYC—germ cell cancer	5.85e-06	0.00694	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	5.83e-06	0.00691	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—germ cell cancer	5.08e-06	0.00603	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CRABP1—germ cell cancer	4.88e-06	0.00579	CbGpPWpGaD
Pemetrexed—DHFR—G1/S Transition—MYC—germ cell cancer	4.87e-06	0.00577	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	4.79e-06	0.00568	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—AVP—germ cell cancer	4.75e-06	0.00563	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	4.35e-06	0.00516	CbGpPWpGaD
Pemetrexed—TYMS—G1/S Transition—MYC—germ cell cancer	4.25e-06	0.00504	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—germ cell cancer	4.18e-06	0.00495	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—FGF4—germ cell cancer	4.17e-06	0.00495	CbGpPWpGaD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—MYC—germ cell cancer	4.1e-06	0.00486	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—SLC2A3—germ cell cancer	4.06e-06	0.00481	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—SLC22A3—germ cell cancer	4e-06	0.00474	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SLC2A3—germ cell cancer	3.89e-06	0.00462	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—H2AFZ—germ cell cancer	3.89e-06	0.00462	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—H2AFZ—germ cell cancer	3.8e-06	0.00451	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—H2AFZ—germ cell cancer	3.72e-06	0.00442	CbGpPWpGaD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—MYC—germ cell cancer	3.58e-06	0.00424	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—KITLG—germ cell cancer	3.43e-06	0.00406	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—H2AFZ—germ cell cancer	3.4e-06	0.00403	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLC2A3—germ cell cancer	3.26e-06	0.00387	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CRABP1—germ cell cancer	3.26e-06	0.00386	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLC22A3—germ cell cancer	3.21e-06	0.00381	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC2A3—germ cell cancer	2.85e-06	0.00337	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC22A3—germ cell cancer	2.8e-06	0.00332	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	2.71e-06	0.00321	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CRABP1—germ cell cancer	2.62e-06	0.00311	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—FGFR3—germ cell cancer	2.55e-06	0.00302	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—KIT—germ cell cancer	2.34e-06	0.00277	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CRABP1—germ cell cancer	2.28e-06	0.00271	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGF4—germ cell cancer	2.24e-06	0.00265	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	2.23e-06	0.00264	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—germ cell cancer	2.14e-06	0.00253	CbGpPWpGaD
Pemetrexed—DHFR—Disease—H2AFZ—germ cell cancer	2e-06	0.00237	CbGpPWpGaD
Pemetrexed—DHFR—Disease—KITLG—germ cell cancer	1.84e-06	0.00218	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MYC—germ cell cancer	1.5e-06	0.00178	CbGpPWpGaD
Pemetrexed—DHFR—Disease—FGFR3—germ cell cancer	1.37e-06	0.00162	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MYC—germ cell cancer	1.34e-06	0.00159	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MYC—germ cell cancer	1.31e-06	0.00156	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MYC—germ cell cancer	1.29e-06	0.00153	CbGpPWpGaD
Pemetrexed—DHFR—Disease—KIT—germ cell cancer	1.25e-06	0.00149	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MYC—germ cell cancer	1.17e-06	0.00139	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—germ cell cancer	1.1e-06	0.00131	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HRAS—germ cell cancer	1.01e-06	0.0012	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—germ cell cancer	9.63e-07	0.00114	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MYC—germ cell cancer	6.9e-07	0.000818	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HRAS—germ cell cancer	5.42e-07	0.000643	CbGpPWpGaD
